PDCD1 and hepatocellular carcinoma: In HCC, it has been shown that the upregulation of PD-1 and PD-L1 induced by various cytokines contributes to the dysfunction of effector T cells, which eventually promotes tumor aggressiveness and recurrence (84, 85).